Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
By C. Kearon, Jeffrey S. Ginsberg, M. Kovacs, D. Anderson, P. Wells, J. Julian, B. Mackinnon, J. Weitz, M. Crowther, S. Dolan and 10 more. New England Journal of Medicine, 2003
727 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Hematology, Internal Medicine
View Paper: https://www.semanticscholar.org/paper/ff38beb9f0f8e64c5f387b1019528d8652cc5afa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Hematology
In Internal Medicine
Citations in the corpus
- Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism (2008, background): “Reduced VKA doses for extended treatment in patients with idiopathic VTE were shown to be effective and safe when compared with placebo,(320) but they were less effective and not safer when compared with conventional intensity anticoagulation.(321)”
- Guidelines on oral anticoagulation with warfarin – fourth edition (2011, background): “For patients who require anticoagulation beyond 3 months, it is not recommended to lower the target range after 3 months as this has been shown to offer poorer efficacy with comparable bleeding rates (Kearon et al, 2003; Ridker et al, 2003).”